| Is there a role for GPCR agonist radiotracers in PET neuroimaging? M Colom, B Vidal, L Zimmer Frontiers in Molecular Neuroscience 12, 255, 2019 | 40 | 2019 |
| Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer’s disease: a post-mortem study with PET radiopharmaceuticals B Vidal, J Sebti, M Verdurand, S Fieux, T Billard, N Streichenberger, ... Neuropharmacology 109, 88-95, 2016 | 39 | 2016 |
| A consensus protocol for functional connectivity analysis in the rat brain J Grandjean, G Desrosiers-Gregoire, C Anckaerts, D Angeles-Valdez, ... Nature neuroscience 26 (4), 673-681, 2023 | 37 | 2023 |
| In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging B Vidal, S Fieux, J Redouté, M Villien, F Bonnefoi, D Le Bars, ... Neuropsychopharmacology 43 (11), 2310-2319, 2018 | 32 | 2018 |
| 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging B Vidal, S Fieux, M Colom, T Billard, C Bouillot, O Barret, ... Brain Structure and Function 223, 2973-2988, 2018 | 26 | 2018 |
| Functional ultrasound imaging to study brain dynamics: application of pharmaco-fUS to atomoxetine B Vidal, M Droguerre, L Venet, L Zimmer, M Valdebenito, F Mouthon, ... Neuropharmacology 179, 108273, 2020 | 17 | 2020 |
| Serotonin 5-HT1A Receptor Biased Agonists Induce Different Cerebral Metabolic Responses: A [18F]-Fluorodesoxyglucose Positron Emission Tomography Study … E Levigoureux, B Vidal, S Fieux, C Bouillot, S Emery, A Newman-Tancredi, ... ACS Chemical Neuroscience 10 (7), 3108-3119, 2018 | 17 | 2018 |
| Pharmaco-fUS for characterizing drugs for Alzheimer’s disease–the case of THN201, a drug combination of donepezil plus Mefloquine B Vidal, M Droguerre, M Valdebenito, L Zimmer, M Hamon, F Mouthon, ... Frontiers in Neuroscience 14, 835, 2020 | 15 | 2020 |
| Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists B Vidal, R Bolbos, J Redouté, JB Langlois, N Costes, ... Neuropharmacology 172, 107867, 2020 | 13 | 2020 |
| StandardRat: A multi-center consensus protocol to enhance functional connectivity specificity in the rat brain J Grandjean, G Desrosiers-Gregoire, C Anckaerts, D Angeles-Valdez, ... bioRxiv, 2022.04. 27.489658, 2022 | 11 | 2022 |
| Bayesian estimation of the ntPET model in single-scan competition PET studies Z Irace, I Mérida, J Redouté, C Fonteneau, MF Suaud-Chagny, J Brunelin, ... Frontiers in Physiology 11, 498, 2020 | 9 | 2020 |
| [18F]F13640, a 5-HT1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations M Colom, B Vidal, S Fieux, J Redoute, N Costes, F Lavenne, I Mérida, ... Frontiers in Neuroscience 15, 622423, 2021 | 8 | 2021 |
| Preclinical validation of [18F] 2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue S Emery, S Fieux, B Vidal, P Courault, S Bouvard, C Tourvieille, T Iecker, ... Nuclear Medicine and Biology 82, 57-63, 2020 | 6 | 2020 |
| Inter-subject registration and application of the SIGMA rat brain atlas for regional labeling in functional ultrasound imaging B Vidal, M Droguerre, L Venet, M Valdebenito, F Mouthon, L Zimmer, ... Journal of Neuroscience Methods 355, 109139, 2021 | 4 | 2021 |
| Different Alterations of Agonist and Antagonist Binding to 5-HT 1A Receptor in a Rat Model of Parkinson’s Disease and Levodopa-Induced Dyskinesia: A MicroPET Study B Vidal, E Levigoureux, S Chaib, C Bouillot, T Billard, ... Journal of Parkinson's disease 11 (3), 1257-1269, 2021 | 4 | 2021 |
| [11C] PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain B Vidal, IA Karpenko, F Liger, S Fieux, C Bouillot, T Billard, M Hibert, ... Nuclear Medicine and Biology 55, 1-6, 2017 | 4 | 2017 |
| Radiopharmacological evaluation of [18F] F13640, a novel 5-HT1A receptor agonist B Vidal, S Fieux, T Billard, A Newman-Tancredi, L Zimmer Journal of Nuclear Medicine 55 (supplement 1), 1100-1100, 2014 | 4 | 2014 |
| Multimodal imaging study of the 5-HT1A receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia S Chaib, B Vidal, C Bouillot, R Depoortere, A Newman-Tancredi, ... NeuroImage: Clinical 39, 103497, 2023 | 3 | 2023 |
| Parasitoses internes P BONIJOL, B VIDAL Université de Lyon1 89, 58, 2012 | 2 | 2012 |
| Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model MD B Vidal, M Pereira, M Valdebenito, L Vidal, F Mouthon, L Zimmer, M Charvériat Journal of Psychopharmacology, 2022 | 1 | 2022 |
